EOLS Stock Price
Evolus, Inc.
$7.10
-$0.47(-6.21%)
38
Overall
40
Value
20
Tech
55
Quality
Market Cap
$468.96M
Volume
761.68K
52W Range
$3.86 - $9.31
Target Price
$15.75
EOLS stock price is $7.10 (-6.21% on the day), giving Evolus, Inc. a market cap of $468.96M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
EOLS Stock Overview
- Price
- $7.10
- Previous close
- $7.57
- Open
- $7.61
- Market cap
- $468.96M
- P/E ratio
- -9.1
- 52-week range
- $3.86 - $9.31
- 1-year price target
- $15.75
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Exchange
- NSD
- MarketXLS Rank
- 38
About Evolus, Inc.
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EOLS | $7.10 | -6.2% | 761.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |